Oracle Commodity Issues Shares for Salaries to Align Management and Shareholder Interests
Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) has announced several share issuances and clarifications regarding previous transactions. The company has issued 84,594 shares since November 1, 2024, as part of a Consulting Agreement with Bayer Law , representing 15% of Mr. Bayer's salary compensation.
Additionally, Oracle clarified details about its June 13, 2024 private placement, revealing that 147,750 Units were issued as Finder's Fees, with Canaccord Genuity Corp. receiving 134,750 Units and Research Capital Corp. receiving 14,000 Units. Each Unit includes one common share and one warrant, with warrants exercisable at $0.15 per Share until June 12, 2027. All securities issued are subject to a four-month regulatory hold period, and the company confirmed these issuances have not created a new Control Person.
Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ha annunciato diverse emissioni di azioni e chiarimenti riguardo a transazioni precedenti. L'azienda ha emesso 84.594 azioni dal 1 novembre 2024, nell'ambito di un Accordo di Consulenza con Bayer Law, che rappresenta il 15% della retribuzione di Mr. Bayer.
Inoltre, Oracle ha chiarito i dettagli riguardanti il collocamento privato del 13 giugno 2024, rivelando che sono state emesse 147.750 Unità come commissioni per i mediatori, con Canaccord Genuity Corp. che ha ricevuto 134.750 Unità e Research Capital Corp. che ha ricevuto 14.000 Unità. Ogni Unità include una azione ordinaria e un warrant, con warrant esercitabili a $0,15 per azione fino al 12 giugno 2027. Tutti i titoli emessi sono soggetti a un periodo di blocco normativo di quattro mesi, e l'azienda ha confermato che queste emissioni non hanno creato una nuova Persona di Controllo.
Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ha anunciado varias emisiones de acciones y aclaraciones sobre transacciones anteriores. La compañía ha emitido 84,594 acciones desde el 1 de noviembre de 2024, como parte de un Acuerdo de Consultoría con Bayer Law, representando el 15% de la compensación salarial del Sr. Bayer.
Además, Oracle aclaró detalles sobre su colocación privada del 13 de junio de 2024, revelando que se emitieron 147,750 Unidades como comisiones para intermediarios, con Canaccord Genuity Corp. recibiendo 134,750 Unidades y Research Capital Corp. recibiendo 14,000 Unidades. Cada Unidad incluye una acción común y un warrant, con warrants ejercitables a $0.15 por acción hasta el 12 de junio de 2027. Todos los valores emitidos están sujetos a un período de retención regulatoria de cuatro meses, y la compañía confirmó que estas emisiones no han creado una nueva Persona de Control.
오라클 커머디티 홀딩 코퍼레이션(주식 코드: ORCL)(OTCQB: ORLCF)은 여러 주식 발행과 이전 거래에 대한 설명을 발표했습니다. 이 회사는 2024년 11월 1일부터 84,594주를 발행했으며, 이는 Bayer Law와의 컨설팅 계약의 일환으로 Mr. Bayer의 급여 보상의 15%에 해당합니다.
또한 오라클은 2024년 6월 13일의 사모 배치에 대한 세부 정보를 명확히 하여 147,750개 유닛이 중개 수수료로 발행되었으며, Canaccord Genuity Corp.는 134,750개 유닛을, Research Capital Corp.는 14,000개 유닛을 받았다고 밝혔습니다. 각 유닛은 하나의 보통주와 하나의 워런트를 포함하며, 워런트는 주당 $0.15로 2027년 6월 12일까지 행사 가능합니다. 발행된 모든 증권은 4개월의 규제 보유 기간에 따라야 하며, 회사는 이러한 발행이 새로운 통제인을 생성하지 않았다고 확인했습니다.
Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) a annoncé plusieurs émissions d'actions et des clarifications concernant des transactions antérieures. La société a émis 84 594 actions depuis le 1er novembre 2024, dans le cadre d'un Accord de Consultation avec Bayer Law, représentant 15 % de la rémunération salariale de M. Bayer.
De plus, Oracle a clarifié les détails concernant son placement privé du 13 juin 2024, révélant que 147 750 unités ont été émises en tant que frais de recherche, avec Canaccord Genuity Corp. recevant 134 750 unités et Research Capital Corp. recevant 14 000 unités. Chaque unité comprend une action ordinaire et un bon de souscription, les bons étant exerçables à 0,15 $ par action jusqu'au 12 juin 2027. Tous les titres émis sont soumis à une période de blocage réglementaire de quatre mois, et la société a confirmé que ces émissions n'ont pas créé de nouvelle personne de contrôle.
Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) hat mehrere Aktienemissionen und Klarstellungen zu früheren Transaktionen angekündigt. Das Unternehmen hat seit dem 1. November 2024 84.594 Aktien im Rahmen eines Beratungsvertrags mit Bayer Law ausgegeben, was 15% des Gehalts von Herrn Bayer entspricht.
Zusätzlich hat Oracle Einzelheiten zu seiner Privatplatzierung vom 13. Juni 2024 klargestellt und bekannt gegeben, dass 147.750 Einheiten als Vermittlungsgebühren ausgegeben wurden, wobei Canaccord Genuity Corp. 134.750 Einheiten und Research Capital Corp. 14.000 Einheiten erhalten hat. Jede Einheit umfasst eine Stammaktie und ein Warrant, wobei Warrants zu $0,15 pro Aktie bis zum 12. Juni 2027 ausgeübt werden können. Alle ausgegebenen Wertpapiere unterliegen einer viermonatigen regulatorischen Sperrfrist, und das Unternehmen hat bestätigt, dass diese Emissionen keine neue Kontrollperson geschaffen haben.
- Alignment of management interests with shareholders through share-based compensation
- Successful completion of private placement with established financial institutions
- Dilution of existing shareholders through new share issuances
- Additional dilution potential from warrant exercise at $0.15 per share
Vancouver, British Columbia--(Newsfile Corp. - February 21, 2025) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that the following Oracle common shares were issued pursuant to a Consulting Agreement with Bayer Law Corporation effective October 2, 2024 and detailed in the news release dated October 3, 2024 (the "Consulting Agreement").
Since November 1, 2024, a total of 84,594 shares have been issued under the Consulting Agreement in lieu of
The table below sets out each individual issuance:
| Name of Officer | Date of Issuance | Number of Shares | CAD$ Amount | Deemed Price per Share |
| Alex Bayer (Bayer Law Corporation) | November 1, 2024 | 15,150 | ||
| Alex Bayer (Bayer Law Corporation) | December 2, 2024 | 20,833 | ||
| Alex Bayer (Bayer Law Corporation) | January 2, 2025 | 27,778 | ||
| Alex Bayer (Bayer Law Corporation) | February 3, 2025 | 20,833 | ||
| TOTAL: | 84,594 |
Securities issued pursuant to the Shares for Services Agreements are subject to regulatory four month hold periods.
The Company confirms that these issuances of shares have not resulted in the creation of a new Control Person.
The Company would also like to clarify certain details from its press release dated June 13, 2024 regarding its private placement transaction. The Company issued 147,750 Units in connection with this Private Placement as Finder's Fees to Canaccord Genuity Corp. (as to 134,750 Units) and Research Capital Corp. (as to 14,000 Units). Each Unit consists of one common share of the Company (a "Share") and one share purchase warrant (the "Warrant") with each Warrant entitling the holder to purchase one additional Share at a price of
About Oracle Commodity Holding Corp.
Oracle Commodity Holding Corp. is a mining royalty company spun out from Silver Elephant Mining Corp. (TSX: ELEF) in 2022.
Further information on Oracle Commodity can be found at www.oracleholding.com.
ORACLE COMMODITY HOLDING CORP.
ON BEHALF OF THE BOARD
"Anthony Garson"
CEO
For more information about Oracle, please contact:
Email: info@oracleholding.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/241848
FAQ
How many shares did Oracle Commodity (ORLCF) issue for consulting services in 2024?
What are the terms of Oracle Commodity's (ORLCF) June 2024 private placement finder's fees?
How long is the hold period for Oracle Commodity's (ORLCF) newly issued shares?
Will Oracle Commodity's (ORLCF) recent share issuances create a new Control Person?
